Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to assess the safety and efficacy of 24-week course of
flibanserin for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in naturally
postmenopausal women.